Fortum Vial (Fortaz Vial)1gm

$8.40

Each Fortum Vial contains 1 gm Ceftazidime Pentahydrate and is an antibiotic useful for the treatment of a number of bacterial infections.

ATC Classification: J01DD02
Active Ingrediant: Ceftazidime
Generic Name: Fortum
Manufacturer: GlaxoSmithKline
Strength: 1gm
Dosage Type: Vial
Packaging Type: Vial in Box
Contains: 1 VIAL

Examples of Packages sent

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Placeholder
Fortum Vial (Fortaz Vial)1gm
$8.40

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Ceftazidime Information


Pronunciation

SEF tay zi deem

 

What is this drug used for?

• It is used to treat bacterial infections.

Frequently reported side effects of this drug

• Diarrhea

• Injection site irritation

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Tremors

• Abnormal movements

• Confusion

• Extra muscle movement

• Dark urine

• Yellow skin or eyes

• Change in amount of urine passed

• Not able to pass urine

• Chills

• Sore throat

• Bruising

• Bleeding

• Severe loss of strength and energy

• Seizures

• Clostridioides (formerly Clostridiumdifficileassociated diarrhea like abdominal pain or cramps, severe diarrhea or watery stools, or bloody stools.

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

 

Medication Safety Issues

Sound-alike/look-alike issues:

CefTAZidime may be confused with ceFAZolin, cefepime, cefoTEtan, cefOXitin, cefTRIAXone

Ceptaz may be confused with Septra

Tazicef may be confused with Tazidime

International issues:

Ceftim [Portugal] and Ceftime [Thailand] brand names for ceftazidime may be confused with Ceftin brand name for cefuroxime [U.S., Canada]; Cefiton brand name for cefixime [Portugal]

 

Storage and Stability

Vials: Store intact vials at 20°C to 25°C (68°F to 77°F). Protect from light. Refer to manufacturer’s labeling for specific storage instructions for reconstituted solution and solution further diluted for IV infusion (varies by diluent).

Duplex container: Store unactivated containers at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light. Do not freeze. Unactivated duplex containers with foil strip removed from the drug chamber must be protected from light and used within 7 days at room temperature. Once activated, must be used within 12 hours if stored at room temperature or within 3 days if stored under refrigeration.

Premixed frozen solution: Store at -20°C (-4°F). Thawed solution is stable for 8 hours at room temperature or for 3 days under refrigeration; do not refreeze.

 

Adverse Reactions

Central nervous system: Seizure

Dermatologic: Pruritus, skin rash

Endocrine & metabolic: Increased gamma-glutamyl transferase, increased lactate dehydrogenase

Gastrointestinal: Diarrhea

Hematologic & oncologic: Agranulocytosis, eosinophilia, leukopenia, lymphocytosis, neutropenia, positive direct Coombs test (without hemolysis), thrombocythemia, thrombocytopenia

Hepatic: Increased serum alkaline phosphatase, increased serum ALT, increased serum AST

Hypersensitivity: Hypersensitivity reactions

Local: Inflammation at injection site, injection site phlebitis

Renal: Increased blood urea nitrogen, increased serum creatinine

Miscellaneous: Fever –

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type